C.R. Bard Inc



) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole closed the day down 1.9%. By the end of trading, C.R. Bard Inc fell $1.87 (-2.1%) to $85.94 on average volume. Throughout the day, 1.1 million shares of C.R. Bard Inc exchanged hands as compared to its average daily volume of one million shares. The stock ranged in price between $85.79-$86.92 after having opened the day at $86.48 as compared to the previous trading day's close of $87.81. Other company's within the Health Services industry that declined today were:

Integra LifeSciences Holdings Inc



), down 16.4%,

BioMimetic Therapeutics Inc



), down 11.7%,

Response Genetics Inc



), down 10.5%, and

China Kanghui Holdings



), down 10.1%.

C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. C.R. Bard Inc has a market cap of $7.6 billion and is part of the

health care

sector. The company has a P/E ratio of 21.6, below the average health services industry P/E ratio of 23.4 and above the S&P 500 P/E ratio of 17.7. Shares are down 5.8% year to date as of the close of trading on Friday.

TheStreet Ratings rates C.R. Bard as a


. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth and expanding profit margins. However, as a counter to these strengths, we find that the stock has experienced relatively poor performance when compared with the S&P 500 during the past year.

On the positive front,

IVAX Diagnostics Inc



), up 7.7%,

RTI Biologics Inc



), up 6.4%,

Celsion Corporation



), up 6.2%, and

Dehaier Medical Systems



), up 5.8%, were all gainers within the health services industry with

Boston Scientific Inc



) being today's featured health services industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care